ClinicalTrials.gg
CompletedNCT06360848Updated Apr 11, 2024

Surgical Treamtment of Pseudarthrosis of the Humerus (Study of a Series of 53 Cases)

An observational study in Humerus Fracture, sponsored by Ibn Jazzar Hospital. Completed. Per ClinicalTrials.gov, last updated 2024-04-11.

Sponsored by Ibn Jazzar Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
53
Sex
All
01

Study summary

Pseudarthrosis of the humerus is a serious complication of humerus fractures, of particular interest to subjects young working people with pseudoarthrogenic risk factors (tobacco++). It represents a real problem therapeutic given the long period of treatment, its disabling socio-professional repercussions and the cost which resulting.

The aim of our work is to evaluate the anatomical and functional results of different surgical techniques. used.

Read the detailed description

The management of pseudarthrosis of the humerus remains a subject of controversy. Given our results, the investigators think that osteosynthesis by plate associated with bone grafting and/or decortication remains the most suitable for the treatment of aseptic pseudarthroses of the humeral shaft while treatment with Ilizarov is most appropriate in septic pseudarthrosis.

However, the best treatment for pseudarthrosis of the humerus remains that of treating the initial fracture. and better control of pseudoarthrogenic risk factors (tobacco++).

02

Conditions studied

  • Humerus Fracture

Keywords

  • humerus
  • pseudarthrosis
  • screwed plate
  • external fixator
03

In context

Humeral Fractures

105 studies on the registry are indexed under Humeral Fractures; 19 are open to participants now.

This study's enrollment of 53 is below the median of 91 across 36 observational studies indexed under Humeral Fractures.

Browse Humeral Fractures studies →

Lead sponsor

Ibn Jazzar Hospital is the lead sponsor of 3 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

53 cases. of pseudarthrosis of the humeral shaft collected at the surgery department orthopedic and traumatology

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

    • Adult men and women > 18 years old with pseudarthrosis of the post-fractured humeral diaphysis treated in the orthopedic surgery and traumatology department.

Exclusion criteria

Exclusion Criteria:

    • Unusable files.
  • Patients lost to follow-up.
  • Patients who did not accept therapeutic treatment.
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
53 participants (actual)
Patient registry
No

Interventions

  • Othersurgery

    SURGICAL TREATMENT OF PSEUDARTHROSIS OF THE HUMERUS

06

What researchers measure

Primary outcomes

  1. Distribution of atrophic pseudarthrosis according to technique surgical procedure used (in Number of patients)

    Surgical technique Screwed plate:5 Percutaneous pinning:12

    Time frame: a minimum follow-up of 10

  2. Distribution of hypertrophic pseudarthrosis according to technique surgical procedure used (in Number of patients)

    Surgical technique Screwed plate:4 Percutaneous pinning:9

    Time frame: a minimum follow-up of 10 months

  3. Time to consolidation depending on the type of pseudarthrosis (in months)

    Atrophic Pseudarthrosis 4.4 months Pseudarthrosis Aseptic 5.28 months Hypertrophic Pseudarthrosis 5.8 months Septic Pseudarthrosis 4.6 months

    Time frame: a minimum follow-up of 10 months

  4. Average Constant score postoperatively according to the means of restraint

    Screwed plate(24) :74 External fixator(28) :64 Nailing centromedullary(1) :69

    Time frame: a minimum follow-up of 10 months

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 11, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06360848
Lead sponsor
Ibn Jazzar Hospital
Responsible party
Zied Mansi (Principal invastigator, Ibn Jazzar Hospital) — Principal investigator
First posted
Apr 11, 2024
Start date
Jan 1, 2005
Primary completion
Jan 1, 2021
Completion
Jan 1, 2021
Last update
Apr 11, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion